Safety and efficacy of transcutaneous auricular vagus nerve stimulation in patients with narcolepsy type 1 (TARGET-2): study protocol for a randomised, double-blind, sham-controlled trial.

Pan Y, Zhang Y, Hu G, Wang X, Yang L, Yuan N, Jia Y, Hao F, Kang J, Ye H, Wen X, Li C, Zhu Z, Wu D, Wu K, Liu Y, TARGET-2 Trial investigator

Open source

DOI
10.1136/bmjopen-2026-121077
Published
2026 Jul 1
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2026-121077,
  title = {Safety and efficacy of transcutaneous auricular vagus nerve stimulation in patients with narcolepsy type 1 (TARGET-2): study protocol for a randomised, double-blind, sham-controlled trial.},
  author = {Pan Y and Zhang Y and Hu G and Wang X and Yang L and Yuan N and Jia Y and Hao F and Kang J and Ye H and Wen X and Li C and Zhu Z and Wu D and Wu K and Liu Y and TARGET-2 Trial investigator},
  year = {2026},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2026-121077},
  url = {https://doi.org/10.1136/bmjopen-2026-121077}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of transcutaneous auricular vagus nerve stimulation in patients with narcolepsy type 1 (TARGET-2): study protocol for a randomised, double-blind, sham-controlled trial.
AU  - Pan Y
AU  - Zhang Y
AU  - Hu G
AU  - Wang X
AU  - Yang L
AU  - Yuan N
AU  - Jia Y
AU  - Hao F
AU  - Kang J
AU  - Ye H
AU  - Wen X
AU  - Li C
AU  - Zhu Z
AU  - Wu D
AU  - Wu K
AU  - Liu Y
AU  - TARGET-2 Trial investigator
PY  - 2026
JO  - BMJ open
DO  - 10.1136/bmjopen-2026-121077
UR  - https://doi.org/10.1136/bmjopen-2026-121077
ER  - 

APA

Y, P., Y, Z., G, H., X, W., L, Y., N, Y., Y, J., F, H., J, K., H, Y., X, W., C, L., Z, Z., D, W., K, W., Y, L., & investigator, T. T. (2026). Safety and efficacy of transcutaneous auricular vagus nerve stimulation in patients with narcolepsy type 1 (TARGET-2): study protocol for a randomised, double-blind, sham-controlled trial.. BMJ open. https://doi.org/10.1136/bmjopen-2026-121077

Source records